29 related articles for article (PubMed ID: 2225561)
1. Minimal change disease induced by tiopronin: a rare case report and a review of the literature.
Zhong H; Wang L; Gu ZC; Cui M; Liu XY; Pang XY
Ann Transl Med; 2019 Aug; 7(16):398. PubMed ID: 31555712
[TBL] [Abstract][Full Text] [Related]
2. Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers.
Erickson SB; Vrtiska TJ; Canzanello VJ; Lieske JC
Urol Res; 2011 Jun; 39(3):197-203. PubMed ID: 21161651
[TBL] [Abstract][Full Text] [Related]
3. Measurement of diurnal variations in urinary cystine saturation.
Lindell A; Denneberg T; Jeppsson JO; Tiselius HG
Urol Res; 1995; 23(4):215-20. PubMed ID: 8533206
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral tiopronin.
Carlsson MS; Denneberg T; Emanuelsson BM; Kågedal B; Lindgren S
Eur J Clin Pharmacol; 1993; 45(1):79-84. PubMed ID: 8405034
[TBL] [Abstract][Full Text] [Related]
5. Clinical course and cystine stone formation during tiopronin treatment.
Lindell A; Denneberg T; Hellgren E; Jeppsson JO; Tiselius HG
Urol Res; 1995; 23(2):111-7. PubMed ID: 7676533
[TBL] [Abstract][Full Text] [Related]
6. [A case of polymyositis complicated with membranous nephritis].
Hara I; Kurata N; Hyozu K; Tamao H
Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):108-9. PubMed ID: 2022901
[No Abstract] [Full Text] [Related]
7. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological study of membranous glomerulonephritis in patients with rheumatoid arthritis].
Shimokama T; Baba N; Shouno Y; Watanabe T; Sakemi T; Harada A
Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):301-7. PubMed ID: 1630032
[TBL] [Abstract][Full Text] [Related]
9. Treatment of clinically normal and cystinuric dogs with 2-mercaptopropionylglycine.
Hoppe A; Denneberg T; Kågedal B
Am J Vet Res; 1988 Jun; 49(6):923-8. PubMed ID: 3400930
[TBL] [Abstract][Full Text] [Related]
10. [Pathohistologic and ultrastructural features of drug-induced membranous glomerulonephritis].
Pospishil' IuA
Arkh Patol; 1996; 58(5):52-6. PubMed ID: 9005826
[TBL] [Abstract][Full Text] [Related]
11. Membranous glomerulonephritis induced by 2-mercaptopropionylglycine (2-MPG).
Lindell A; Denneberg T; Eneström S; Fich C; Skogh T
Clin Nephrol; 1990 Sep; 34(3):108-15. PubMed ID: 2225561
[TBL] [Abstract][Full Text] [Related]
12. A case of nephrotic syndrome due to alpha-mercaptopropionyl glycine in a patient with familial cystinuria.
Shibasaki T; Murai S; Kodama K; Nakano H; Ishimoto F; Sakai O
Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):933-7. PubMed ID: 2250412
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
